Integrin expression in localized prostate cancer: a TCGA and MSKCC cohort-based exploratory in silico analysis

Background/Aim: Diagnostic and prognostic biomarkers in localized prostate cancer (PC) are insufficient. Treatment stratification relies on prostate-specific antigen, clinical tumor staging and International Society of Urological Pathology (ISUP) grading, whereas molecular profiling remains unused....

Full description

Saved in:
Bibliographic Details
Main Authors: Neuberger, Manuel (Author) , Frey, Lisa (Author) , Nitschke, Katja (Author) , Wessels, Frederik (Author) , Westhoff, Niklas Christian (Author) , Waldbillig, Frank (Author) , Nientiedt, Malin (Author) , Hartung, Friedrich (Author) , Hardenberg, Jost von (Author) , Michel, Maurice Stephan (Author) , Erben, Philipp (Author) , Nuhn, Philipp (Author) , Worst, Thomas (Author)
Format: Article (Journal)
Language:English
Published: January 2023
In: Anticancer research
Year: 2023, Volume: 43, Issue: 1, Pages: 417-428
ISSN:1791-7530
DOI:10.21873/anticanres.16177
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21873/anticanres.16177
Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/43/1/417
Get full text
Author Notes:Manuel Neuberger, Lisa Frey, Katja Nitschke, Frederik Wessels, Niklas Westhoff, Frank Waldbillig, Malin Nientiedt, Friedrich Hartung, Jost Von Hardenberg, Maurice Stephan Michel, Philipp Erben, Philipp Nuhn and Thomas Stefan Worst

MARC

LEADER 00000caa a2200000 c 4500
001 1848769156
003 DE-627
005 20230706204301.0
007 cr uuu---uuuuu
008 230612s2023 xx |||||o 00| ||eng c
024 7 |a 10.21873/anticanres.16177  |2 doi 
035 |a (DE-627)1848769156 
035 |a (DE-599)KXP1848769156 
035 |a (OCoLC)1389529734 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Neuberger, Manuel  |e VerfasserIn  |0 (DE-588)118332331X  |0 (DE-627)1663137250  |4 aut 
245 1 0 |a Integrin expression in localized prostate cancer  |b a TCGA and MSKCC cohort-based exploratory in silico analysis  |c Manuel Neuberger, Lisa Frey, Katja Nitschke, Frederik Wessels, Niklas Westhoff, Frank Waldbillig, Malin Nientiedt, Friedrich Hartung, Jost Von Hardenberg, Maurice Stephan Michel, Philipp Erben, Philipp Nuhn and Thomas Stefan Worst 
264 1 |c January 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht 30. Dezember 2022 
500 |a Gesehen am 12.06.2023 
520 |a Background/Aim: Diagnostic and prognostic biomarkers in localized prostate cancer (PC) are insufficient. Treatment stratification relies on prostate-specific antigen, clinical tumor staging and International Society of Urological Pathology (ISUP) grading, whereas molecular profiling remains unused. Integrins (ITG) have an important function in bidirectional signaling and are associated with progression, proliferation, perineural invasion, angiogenesis, metastasis, neuroendocrine differentiation, and a more aggressive disease phenotype in PC. However, ITG subunit expression in localized PC and their utility as prognostic biomarkers has not yet been analyzed. This study aimed to fill this gap and provide a comprehensive overview of ITG expression as well as ITG utility as biomarkers. Patients and Methods: The Cancer Genome Atlas (TCGA) and the Memorial Sloan Kettering Cancer Center (MSKCC) prostate adenocarcinoma cohorts were analyzed regarding ITG expression in correlation to ISUP, N- and American Joint Committee on Cancer (AJCC) stage and were correlated with disease-free survival (DFS). Statistical tests used included the Mann-Whitney U-test, logrank test and uni- and multivariable cox regression analyses. Results: After grouping for ISUP (1 and 2 vs. 3-5), N0 vs. N1 and AJCC stage (≤2 vs. ≥3), multiple ITGs showed significant expression differences. The most consistent results were observed for ITGα4, ITGαX, ITGα11, ITGβ2 and ITGα2. In multivariable cox regression, ITGα2, ITGα10, ITGαD, ITGαB2 (TCGA), ITGα11 and ITGβ4 (MSKCC) were independent predictors of DFS. Conclusion: The utility of ITGs as PC biomarkers was herein shown. 
650 4 |a Biomarkers 
650 4 |a disease-free survival 
650 4 |a integrins 
650 4 |a localized prostate cancer 
650 4 |a prognosis 
700 1 |a Frey, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Nitschke, Katja  |d 1984-  |e VerfasserIn  |0 (DE-588)1075770823  |0 (DE-627)833830651  |0 (DE-576)444648046  |4 aut 
700 1 |a Wessels, Frederik  |d 1990-  |e VerfasserIn  |0 (DE-588)1183323255  |0 (DE-627)1663137226  |4 aut 
700 1 |a Westhoff, Niklas Christian  |d 1988-  |e VerfasserIn  |0 (DE-588)107322306X  |0 (DE-627)828672628  |0 (DE-576)434741752  |4 aut 
700 1 |a Waldbillig, Frank  |d 1988-  |e VerfasserIn  |0 (DE-588)1142198081  |0 (DE-627)1001323572  |0 (DE-576)494739932  |4 aut 
700 1 |a Nientiedt, Malin  |d 1991-  |e VerfasserIn  |0 (DE-588)114835476X  |0 (DE-627)1008678988  |0 (DE-576)496269860  |4 aut 
700 1 |a Hartung, Friedrich  |d 1993-  |e VerfasserIn  |0 (DE-588)1223629066  |0 (DE-627)1743101791  |4 aut 
700 1 |a Hardenberg, Jost von  |d 1982-  |e VerfasserIn  |0 (DE-588)1020494328  |0 (DE-627)688149278  |0 (DE-576)360578241  |4 aut 
700 1 |a Michel, Maurice Stephan  |d 1970-  |e VerfasserIn  |0 (DE-588)121842568  |0 (DE-627)705674134  |0 (DE-576)29291363X  |4 aut 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
700 1 |a Nuhn, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)136112951  |0 (DE-627)694090808  |0 (DE-576)30083909X  |4 aut 
700 1 |a Worst, Thomas  |d 1985-  |e VerfasserIn  |0 (DE-588)1028335679  |0 (DE-627)73058500X  |0 (DE-576)375827501  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 43(2023), 1 vom: Jan., Seite 417-428  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a Integrin expression in localized prostate cancer a TCGA and MSKCC cohort-based exploratory in silico analysis 
773 1 8 |g volume:43  |g year:2023  |g number:1  |g month:01  |g pages:417-428  |g extent:12  |a Integrin expression in localized prostate cancer a TCGA and MSKCC cohort-based exploratory in silico analysis 
856 4 0 |u https://doi.org/10.21873/anticanres.16177  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ar.iiarjournals.org/content/43/1/417  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230612 
993 |a Article 
994 |a 2023 
998 |g 1028335679  |a Worst, Thomas  |m 1028335679:Worst, Thomas  |d 60000  |d 63100  |e 60000PW1028335679  |e 63100PW1028335679  |k 0/60000/  |k 1/60000/63100/  |p 13  |y j 
998 |g 136112951  |a Nuhn, Philipp  |m 136112951:Nuhn, Philipp  |d 60000  |d 63100  |e 60000PN136112951  |e 63100PN136112951  |k 0/60000/  |k 1/60000/63100/  |p 12 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 63100  |e 60000PE128501014  |e 63100PE128501014  |k 0/60000/  |k 1/60000/63100/  |p 11 
998 |g 121842568  |a Michel, Maurice Stephan  |m 121842568:Michel, Maurice Stephan  |d 60000  |d 63100  |e 60000PM121842568  |e 63100PM121842568  |k 0/60000/  |k 1/60000/63100/  |p 10 
998 |g 1020494328  |a Hardenberg, Jost von  |m 1020494328:Hardenberg, Jost von  |d 60000  |d 63100  |e 60000PH1020494328  |e 63100PH1020494328  |k 0/60000/  |k 1/60000/63100/  |p 9 
998 |g 1223629066  |a Hartung, Friedrich  |m 1223629066:Hartung, Friedrich  |d 60000  |d 63100  |e 60000PH1223629066  |e 63100PH1223629066  |k 0/60000/  |k 1/60000/63100/  |p 8 
998 |g 114835476X  |a Nientiedt, Malin  |m 114835476X:Nientiedt, Malin  |p 7 
998 |g 1142198081  |a Waldbillig, Frank  |m 1142198081:Waldbillig, Frank  |p 6 
998 |g 107322306X  |a Westhoff, Niklas Christian  |m 107322306X:Westhoff, Niklas Christian  |d 60000  |d 63100  |e 60000PW107322306X  |e 63100PW107322306X  |k 0/60000/  |k 1/60000/63100/  |p 5 
998 |g 1183323255  |a Wessels, Frederik  |m 1183323255:Wessels, Frederik  |d 60000  |d 63100  |e 60000PW1183323255  |e 63100PW1183323255  |k 0/60000/  |k 1/60000/63100/  |p 4 
998 |g 1075770823  |a Nitschke, Katja  |m 1075770823:Nitschke, Katja  |d 60000  |d 63100  |e 60000PN1075770823  |e 63100PN1075770823  |k 0/60000/  |k 1/60000/63100/  |p 3 
998 |g 118332331X  |a Neuberger, Manuel  |m 118332331X:Neuberger, Manuel  |d 60000  |d 63100  |e 60000PN118332331X  |e 63100PN118332331X  |k 0/60000/  |k 1/60000/63100/  |p 1  |x j 
999 |a KXP-PPN1848769156  |e 4331312364 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1848769156","name":{"displayForm":["Manuel Neuberger, Lisa Frey, Katja Nitschke, Frederik Wessels, Niklas Westhoff, Frank Waldbillig, Malin Nientiedt, Friedrich Hartung, Jost Von Hardenberg, Maurice Stephan Michel, Philipp Erben, Philipp Nuhn and Thomas Stefan Worst"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"January 2023"}],"person":[{"role":"aut","family":"Neuberger","display":"Neuberger, Manuel","given":"Manuel"},{"family":"Frey","display":"Frey, Lisa","given":"Lisa","role":"aut"},{"role":"aut","given":"Katja","display":"Nitschke, Katja","family":"Nitschke"},{"role":"aut","family":"Wessels","given":"Frederik","display":"Wessels, Frederik"},{"role":"aut","display":"Westhoff, Niklas Christian","given":"Niklas Christian","family":"Westhoff"},{"family":"Waldbillig","given":"Frank","display":"Waldbillig, Frank","role":"aut"},{"given":"Malin","display":"Nientiedt, Malin","family":"Nientiedt","role":"aut"},{"role":"aut","display":"Hartung, Friedrich","given":"Friedrich","family":"Hartung"},{"role":"aut","display":"Hardenberg, Jost von","given":"Jost von","family":"Hardenberg"},{"role":"aut","given":"Maurice Stephan","display":"Michel, Maurice Stephan","family":"Michel"},{"role":"aut","display":"Erben, Philipp","given":"Philipp","family":"Erben"},{"role":"aut","given":"Philipp","display":"Nuhn, Philipp","family":"Nuhn"},{"family":"Worst","given":"Thomas","display":"Worst, Thomas","role":"aut"}],"language":["eng"],"title":[{"title":"Integrin expression in localized prostate cancer","subtitle":"a TCGA and MSKCC cohort-based exploratory in silico analysis","title_sort":"Integrin expression in localized prostate cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1848769156"],"doi":["10.21873/anticanres.16177"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"note":["Gesehen am 26.02.13"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["387478493"],"zdb":["2145376-7"],"issn":["1791-7530"]},"part":{"volume":"43","text":"43(2023), 1 vom: Jan., Seite 417-428","year":"2023","pages":"417-428","extent":"12","issue":"1"},"title":[{"subtitle":"international journal of cancer research and treatment","title_sort":"Anticancer research","title":"Anticancer research"}],"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisher":"International Institute of Anticancer Research"}],"name":{"displayForm":["International Institute of Anticancer Research"]},"pubHistory":["Nachgewiesen 24.2004 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"disp":"Integrin expression in localized prostate cancer a TCGA and MSKCC cohort-based exploratory in silico analysisAnticancer research","recId":"387478493"}],"note":["Online veröffentlicht 30. Dezember 2022","Gesehen am 12.06.2023"]} 
SRT |a NEUBERGERMINTEGRINEX2023